Vincerx Pharma Files Proxy Statement for June Meeting
Ticker: VINC · Form: DEF 14A · Filed: May 12, 2025 · CIK: 1796129
| Field | Detail |
|---|---|
| Company | Vincerx Pharma, Inc. (VINC) |
| Form Type | DEF 14A |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
Related Tickers: VINC
TL;DR
Vincerx Pharma (VINC) proxy filed. Vote on exec pay & board seats by June 18. Don't miss it!
AI Summary
Vincerx Pharma, Inc. filed its definitive proxy statement (DEF 14A) on May 12, 2025, for its annual meeting on June 18, 2025. The company, formerly known as LifeSci Acquisition Corp. and Vincera Pharma, Inc., is seeking shareholder approval for matters related to its corporate governance and operations. The filing details executive compensation, board nominations, and other proposals requiring shareholder votes.
Why It Matters
This filing provides shareholders with crucial information about the company's leadership, executive compensation, and upcoming proposals, enabling informed voting decisions that can impact the company's strategic direction.
Risk Assessment
Risk Level: medium — Proxy statements often contain information about executive compensation, board composition, and shareholder proposals, which can signal potential changes in strategy or governance that may affect stock price.
Key Players & Entities
- Vincerx Pharma, Inc. (company) — Registrant
- LifeSci Acquisition Corp. (company) — Former Company Name
- Vincera Pharma, Inc. (company) — Former Company Name
- 20250512 (date) — Filing Date
- 20250618 (date) — Meeting Date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting on June 18, 2025, including details on proposals requiring shareholder votes, executive compensation, and board nominations.
When was this proxy statement filed with the SEC?
This definitive proxy statement was filed on May 12, 2025.
What were Vincerx Pharma's former names?
Vincerx Pharma, Inc. was formerly known as Vincera Pharma, Inc. and prior to that, LifeSci Acquisition Corp.
What is the company's fiscal year end?
The company's fiscal year end is December 31st.
Where is Vincerx Pharma, Inc. headquartered?
Vincerx Pharma, Inc. is headquartered in Palo Alto, California, with a business address at 260 Sheridan Avenue, Suite 400, Palo Alto, CA 94306.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 12, 2025 regarding Vincerx Pharma, Inc. (VINC).